SOMERVILLE KURT F - NOVOZYMES A S DKK 2.0 ownership

NOVOZYMES A S DKK 2.0's ticker is and the CUSIP is B798FW902. A total of 6 filers reported holding NOVOZYMES A S DKK 2.0 in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SOMERVILLE KURT F ownership history of NOVOZYMES A S DKK 2.0
ValueSharesWeighting
Q3 2023$1,211,240
-13.3%
30,0880.0%0.24%
-8.3%
Q2 2023$1,397,443
-28.3%
30,088
-21.4%
0.27%
-25.3%
Q1 2023$1,949,557
-10.7%
38,290
-11.4%
0.36%
-16.0%
Q4 2022$2,183,519
-23.1%
43,240
-23.2%
0.42%
-25.6%
Q3 2022$2,839,000
-28.3%
56,325
-14.8%
0.57%
-24.2%
Q2 2022$3,961,000
-28.0%
66,125
-17.4%
0.75%
-15.1%
Q1 2022$5,501,000
-36.2%
80,060
-23.9%
0.89%
-25.9%
Q4 2021$8,621,000
-1.6%
105,170
-18.0%
1.20%
-10.2%
Q3 2021$8,763,000
-26.7%
128,250
-19.3%
1.33%
-25.4%
Q2 2021$11,952,000
-2.8%
158,938
-17.4%
1.78%
-8.3%
Q1 2021$12,296,000
+6.7%
192,516
-4.4%
1.94%
+3.7%
Q4 2020$11,524,000
-10.5%
201,293
-1.8%
1.88%
-17.3%
Q3 2020$12,876,000
+8.0%
204,950
-0.9%
2.27%
+3.1%
Q2 2020$11,927,000
+24.7%
206,900
-1.4%
2.20%
+3.7%
Q1 2020$9,562,000
-8.0%
209,880
-1.4%
2.12%
+8.7%
Q4 2019$10,389,000
+15.0%
212,919
-1.1%
1.95%
+9.2%
Q3 2019$9,030,000
-9.4%
215,323
+0.5%
1.78%
-9.7%
Q2 2019$9,962,000
-1.3%
214,273
-2.7%
1.98%
-1.3%
Q1 2019$10,097,000
+5.7%
220,141
+2.7%
2.00%
-8.6%
Q4 2018$9,550,000
-18.6%
214,450
-0.0%
2.19%
-6.7%
Q3 2018$11,738,000
+8.7%
214,510
+0.6%
2.35%
-1.5%
Q2 2018$10,803,000
-2.5%
213,255
-0.8%
2.38%
-2.7%
Q1 2018$11,080,000
-16.2%
214,945
-7.4%
2.45%
-10.4%
Q4 2017$13,217,000
+1.3%
232,030
-8.9%
2.73%
+5.0%
Q3 2017$13,047,000
+17.0%
254,755
-0.0%
2.60%
+14.4%
Q2 2017$11,150,000
+13.4%
254,805
+2.7%
2.28%
+9.5%
Q1 2017$9,836,000
+16.8%
248,120
+1.6%
2.08%
+11.4%
Q4 2016$8,422,000
-21.7%
244,325
-0.2%
1.87%
-20.4%
Q3 2016$10,762,000
-4.9%
244,694
+4.0%
2.34%
-7.8%
Q2 2016$11,314,000
+9.2%
235,240
+2.1%
2.54%
+7.6%
Q1 2016$10,359,000
-8.9%
230,445
-2.4%
2.36%
-8.9%
Q4 2015$11,367,000
+18.9%
236,107
+7.6%
2.60%
+6.6%
Q3 2015$9,559,000
-7.4%
219,413
+1.0%
2.44%
+2.0%
Q2 2015$10,326,000
+3.0%
217,228
-0.8%
2.39%
+4.7%
Q1 2015$10,025,000
+24.8%
219,038
+15.1%
2.28%
+14.1%
Q4 2014$8,031,000
+64.3%
190,258
+68.9%
2.00%
+1.4%
Q3 2014$4,887,000
-15.4%
112,635
-2.2%
1.97%
-12.4%
Q2 2014$5,778,000
+11.4%
115,195
-2.3%
2.25%
+9.1%
Q1 2014$5,187,000
+3.7%
117,965
-0.5%
2.06%
+7.8%
Q4 2013$5,003,000
-0.2%
118,500
-9.5%
1.92%
-4.1%
Q3 2013$5,011,000
+19.4%
131,000
-0.1%
2.00%
+13.3%
Q2 2013$4,196,000
-8.0%
131,100
-2.5%
1.76%
-6.7%
Q1 2013$4,561,000
+17.2%
134,510
-2.8%
1.89%
+8.5%
Q4 2012$3,892,000138,3401.74%
Other shareholders
NOVOZYMES A S DKK 2.0 shareholders Q3 2023
NameSharesValueWeighting ↓
Delaney Dennis R 32,907$1,897,0002.54%
Fayerweather Charles 22,858$1,318,0002.31%
SOMERVILLE KURT F 206,900$11,927,0002.20%
Gardiner Nancy B 22,350$1,288,0002.13%
Broderick Brian C 106,579$6,143,0002.04%
PUZO MICHAEL J 93,960$5,416,0002.03%
Kidder Stephen W 90,846$5,237,0002.00%
Page Arthur B 37,705$2,173,0001.92%
Dempze Nancy E 26,893$1,549,0001.73%
Hemenway Trust Co LLC 206,922$11,927,0001.66%
View complete list of NOVOZYMES A S DKK 2.0 shareholders